7 Jul

UK Supreme Court quashes £220 million third-party lawsuit against patent litigant

Pharma rights holders in the UK will be relieved that the NHS has failed to overturn rules barring third parties from seeking compensation for losses resulting from the enforcement of patents later invalidated

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth